8-KEarnings & ResultsExhibits & Filings

Edwards Lifesciences Corp 8-K Report, Financial Results (Oct 24, 2024)

Filed October 24, 2024For Securities:EW

Summary

Edwards Lifesciences Corporation (EW) has filed a Form 8-K to report its financial results for the third quarter of 2024, as detailed in a press release dated October 24, 2024. While the filing itself is brief and primarily serves to incorporate the press release, the information contained within that release is crucial for investors to understand the company's recent performance and financial condition. Investors should focus on the details within the furnished press release (Exhibit 99.1) for specific figures regarding revenue, profitability, and any forward-looking guidance. This 8-K signals the official release of Q3 2024 earnings and provides the foundational data upon which further analysis of the company's operational success and strategic direction can be built. The filing itself does not contain new financial statements or operational commentary beyond referencing the press release.

Key Highlights

  • 1Edwards Lifesciences (EW) reported its financial results for the third quarter of 2024.
  • 2The Q3 2024 financial results were disclosed via a press release dated October 24, 2024.
  • 3The press release containing the Q3 2024 financial results is furnished as Exhibit 99.1 to the 8-K filing.
  • 4This filing incorporates by reference the information from the press release.
  • 5The 8-K filing itself does not contain detailed financial statements or operational commentary, directing investors to the press release for specifics.
  • 6The event date for this disclosure was October 23, 2024, with the filing occurring on October 23, 2024.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially announce and provide access to Edwards Lifesciences' financial results for the third quarter of 2024. It does this by incorporating a press release containing these results.

The detailed Q3 2024 financial results are located in the press release dated October 24, 2024, which is furnished as Exhibit 99.1 to this 8-K filing and incorporated by reference.

No, this 8-K filing itself does not include new financial statements or management's discussion and analysis. It serves primarily to present the press release containing the Q3 2024 results.

The information furnished under Item 2.02, including the press release, is not considered 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934. This means the company typically assumes less liability for the accuracy of furnished information compared to filed information, although it is still material non-public information being disclosed.